Back to top

New Strong Buy Stocks for October 31st

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday:

Enova International, Inc. (ENVA - Free Report) : This technology and analytics company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.6% over the last 60 days.

Mercury General Corporation (MCY - Free Report) : This company that engages in writing personal automobile insurance has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.3% over the last 60 days.

Mercury General Corporation Price and Consensus

 

Mercury General Corporation Price and Consensus

Mercury General Corporation price-consensus-chart | Mercury General Corporation Quote

Generac Holdings Inc. (GNRC - Free Report) : This company that designs, manufactures, and sells power generation equipment and other engine powered products has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.Omnicell, Inc. (OMCL - Free Report) : This company that provides automation and business analytics software solutions has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.

Omnicell, Inc. Price and Consensus

 

Omnicell, Inc. Price and Consensus

Omnicell, Inc. price-consensus-chart | Omnicell, Inc. Quote

Orthofix Medical Inc. (OFIX - Free Report) : This medical device company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.

Orthofix International N.V. Price and Consensus

 

Orthofix International N.V. Price and Consensus

Orthofix International N.V. price-consensus-chart | Orthofix International N.V. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>



More from Zacks Zacks #1 Rank Additions

You May Like